Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-1352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L23-142 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L23-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L53-00 |
filingDate |
2005-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eef16a70da91014c05f2f297007791fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f10235785cbc4319b92b0619bbc3109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19eaadb5c9f1eadde2f20e1d5feb5676 |
publicationDate |
2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1829545-A4 |
titleOfInvention |
PRODUCTS CONTAINING A PROSTAGLANDIN F2 ALPHA DERIVATIVE |
abstract |
The invention provides a resin-made container which enables long-term stable preservation of aqueous liquid preparations containing prostaglandin F2α derivatives having fluorine atoms in the molecule. An aqueous liquid preparation containing a prostaglandin F2α derivative having a fluorine atom in the molecule is protected from lowering in the prostaglandin F2α derivative content by keeping the preparation in a container made of a propylene/ethylene copolymer having a propylene/ ethylene ratio of 94.0/6.0 to 99.5/0.5. |
priorityDate |
2004-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |